I believe due the fact there are only 34 million OS and a extremely small public float, $2.00 is not out of the question.
It is a clean shell, no debt and comes complete with tax credits. It is well worth a lot more than what it is currently trading at right now just for those facts.
You start adding in all the possible scenarios and we could be looking @ a $10.00 stock. Most Biotech companies are buried in debt and trading well above $5.00.
The one scenario that could easily shoot us past $2.00 is the J&J settlement. Any ideas what Palmaz is receiving in residuals from J&J? I estimate around 20%. If so, on the lawsuit alone, he could make well over $140 million. Let us play devil's advocate. Let us say his residuals are on only 5%. That would still be $35 million coming his way.
No need for an IPO. They already have Steven B. Solomon, a clean shell, with no debt and tax credits. Now they are going to be sitting on tons of cash.
A new stent, (Sesame) about ready, if not ready to hit the market. Tons of patents and well over 170 pending patents.
No matter, how you slice it, Palmaz is going to be receiving a substantial amount of money in the near future, interest free! Yes, of course, he is not just going to hand it over to the company. I assure you, they will be using that money wisely. Even if they never announce it; I assure you we will be pleasantly pleaseed when they announce their earnings. That cash will end up on the books in some capacity. At least some of it, if not all of it.
Disclamier: This is all just my opinion and my opinion only. I do not work for Palmaz Scientific or CWDW. I do not know of anyone that works for either company or anyone doing any business with either company. I am strictly a shareholder hoping something positive plays out for me and for the rest of the individuals who have made and investment into CWDW's future. This is not a recommendation to buy CWDW and I am not a professional financial advisor. Please seek professional financial advice before investing in CWDW.
AI
